Science
Mechanism of Action
Oligopeptide-47 (Oligopeptide-68) acts as a potent skin-brightening agent by interacting with the microphthalmia-associated transcription factor (MITF). This interaction specifically inhibits the differentiation and development of melanocytes, thereby reducing tyrosinase activity and subsequently decreasing melanin synthesis. This targeted mechanism effectively addresses concerns such as melasma, hyperpigmentation, and dark spots, contributing to the lightening of both intrinsic and environmentally induced pigmentation.
Research
Clinical Evidence
High confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Oligopeptide-47 (Oligopeptide-68) maintains stability for 24 months from manufacture when stored at a controlled temperature range of -20°C to -15°C in a freezer, protected from light, and in an air-proofed package. Cold storage helps prevent degradation from residual water. It is susceptible to enzymatic decomposition by microorganisms, necessitating stringent control against microbial contamination during processing.
Conflicts
- Microbial contamination
Safety
Safety Profile
While specific safety statuses from CIR, SCCS, or FDA for Oligopeptide-47 (Oligopeptide-68) are not documented, peptides generally demonstrate good tolerability across all skin types. Clinical trials involving Oligopeptide-68 have reported no severe adverse reactions, with temporary mild skin reactions being the most common. Although peptides are often considered safe during pregnancy, medical consultation is always advised.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Oligopeptide-47, or Oligopeptide-68, is a highly valuable decapeptide for precision skincare, demonstrating strong clinical efficacy in diminishing various forms of hyperpigmentation and promoting a uniform, brighter skin tone through its specific melanin-inhibiting mechanism.
Related
Similar Ingredients
Finding similar ingredients…